EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation

Amin Polzin, Daniel Scheiber, Fabian Voss iD, Jean Haurand, Elric Zweck, Daniel Oehler, Oliver Maier, Mareike Cramer, Maximilian Spieker, Constanze Moos, Ursala Tokhi, David Naguib und 10 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15330 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Amin Polzin und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pulmonology, and Vascular Medicine, Medical, Faculty of Heinrich Heine University, University Hospital Düsseldorf, Düsseldo…. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Myocardium, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Heart Foundation, Medical Faculty of the Heinrich Heine University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Heart transplantation (HTX) is the treatment of choice for advanced heart failure. Still, long-term survival needs to be improved. Recent studies showed that obesity and type 2 diabetes (T2D) as well as impaired renal and liver function are associated with mortality post-HTX. There are many open questions including (i) optimal metabolic surveillance post-transplant, (ii) association of metabolic deterioration and cardiac function, (iii) association with hepatic and renal deterioration, and (iv) optimal timing and choice of treatment. The METAB-HTX trial will address these open questions, hypothesizing that metabolic deterioration post-HTX is associated with impaired cardiac function and survival. Methods and results METAB-HTX is a prospective, longitudinal cohort study, enrolling 400 patients post-HTX in a period of 5 years. Time-series, deep cardiac, and metabolic phenotyping will be conducted. Cardiac function will be analysed by echocardiography as well as serial cardiac magnetic resonance imaging and spectroscopy (cMRI/MRS). Coronary angiography will be conducted to assess both macrovascular and microvascular coronary allograft vasculopathy (CAV). To evaluate allograft rejection, endomyocardial biopsies will be taken. Metabolic alterations will be investigated by (i) glucometabolic phenotyping including serial oral glucose tolerance tests, homeostasis model assessment, T2D endotyping, and muscle biopsies in selected cases; (ii) lipid disorders will be evaluated by classical lipid measurements in combination with evaluation of HDL function, plasma membrane lipid composition, fluidity analyses of circulating cells and MRI/MRS for adipose tissue distribution, and ectopic fat analysis. Kidney and liver function and structural alterations will be evaluated. Complex analyses will be conducted to evaluate (i) myocardial substrate utilization and energy metabolism by cardiac and circulating cell respirometry, (ii) impact of genetic (including immunogenetic) and transcriptomic factors by third- and fourth generation sequencing (short- and long-read sequencing), (iii) circulating signatures of future neoplasia by single-cell sequencing of circulating leucocytes, and (iv) evaluation of thromboinflammation in association with heart transplant events. The primary endpoint will be the incidence of heart transplant events, defined as worsening of systolic or diastolic left ventricular function, CAV, allograft rejection, worsening of kidney function, metabolic liver disease, infections, neoplasia, deterioration of glucose and lipid metabolism. Secondary outcomes include hospitalizations related to primary endpoints, re-HTX or ventricular assist device, cardiovascular mortality, and all-cause mortality.

Conclusions

The METAB-HTX trial will identify early metabolic alterations potentially impairing cardiac function and outcome of HTX patients. This will identify patients at risk and allow precise planning of interventional trials to treat metabolic alterations post-HTX and improve outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart FailureMyocardiumMetabolomicsHumansProspective StudiesLongitudinal StudiesMaleFemaleFollow-Up StudiesMiddle AgedEchocardiography

Stichwörter der Autor:innen

DiabetesHeart transplantationLong‐term survivalMetabolism

Autor:innen und Institutionen

  • Department of Cardiology, Pulmonology, and Vascular Medicine, Medical, Faculty of Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Cardiovascular Research Institute Düsseldorf (CARID), Heinrich Heine University, Düsseldorf, Germany.
  • Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • German Center for Diabetes Research, Partner Düsseldorf, München-Neuherberg, Germany.
  • Institute for Cardiac Diagnostics and Therapy (IKDT), Berlin, Germany.

ORCID-Profile: Fabian Voss

Förderung

  • Deutsche Forschungsgemeinschaft
  • German Heart Foundation
  • Medical Faculty of the Heinrich Heine University
  • Deutsche Herzstiftung

Zitieren

APA

Polzin, A., Scheiber, D., Voss, F., Haurand, J., Zweck, E., Oehler, D., Maier, O., Cramer, M., Spieker, M., Moos, C., Tokhi, U., Naguib, D., Mourikis, P., Benkhoff, M., Wagner, R., Roden, M., Schultheiss, H. P., Dietrich, S., Aubin, H., …, & Kelm, M. (2025). METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation. ESC Heart Failure. https://doi.org/10.1002/ehf2.15330

Vancouver

Polzin A, Scheiber D, Voss F, Haurand J, Zweck E, Oehler D, et al. METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation. ESC Heart Failure. 2025. doi:10.1002/ehf2.15330

BibTeX
@article{Polzin2025,
  author = {Polzin, Amin and Scheiber, Daniel and Voss, Fabian and Haurand, Jean and Zweck, Elric and Oehler, Daniel and Maier, Oliver and Cramer, Mareike and Spieker, Maximilian and Moos, Constanze and Tokhi, Ursala and Naguib, David and Mourikis, Philipp and Benkhoff, Marcel and Wagner, Robert and Roden, Michael and Schultheiss, Heinz-Peter and Dietrich, Sascha and Aubin, Hug and Boeken, Udo and Lichtenberg, Artur and Kelm, Malte},
  title = {METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15330}
}
Kostenlos starten →